Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Perfil de Nutriband Inc



Símbolo de cotizaciónNTRB

Nombre de la empresaNutriband Inc

Fecha de salida a bolsaJun 20, 2017

Director ejecutivoMelnik (Serguei)

Número de empleados- -

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 20

Dirección121 S Orange Ave Ste 1500

CiudadORLANDO

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal32801-3241

Teléfono14073776695

Sitio Webhttps://nutriband.com/

Símbolo de cotizaciónNTRB

Fecha de salida a bolsaJun 20, 2017

Director ejecutivoMelnik (Serguei)

Ejecutivos de Nutriband Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Gareth Sheridan

Chief Executive Officer, Founder, Director

1.79M

+15.45%

Mr. Gareth Sheridan

Chief Executive Officer, Founder, Director

1.79M

+15.45%

Mr. Gareth Sheridan

Chief Executive Officer, Founder, Director

1.79M

+15.45%

Mr. Serguei Melnik

Chairman of the Board, President, Company Secretary

839.00K

-11.97%

Mr. Serguei Melnik

Chairman of the Board, President, Company Secretary

839.00K

-11.97%

Mr. Serguei Melnik

Chairman of the Board, President, Company Secretary

839.00K

-11.97%

Mr. Gerald Goodman

Chief Financial Officer

86.33K

Mr. Gerald Goodman

Chief Financial Officer

86.33K

Mr. Gerald Goodman

Chief Financial Officer

86.33K

Dr. Jeff Patrick, Pharm.D.

Chief Scientific Officer

36.61K

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Gareth Sheridan

Chief Executive Officer, Founder, Director

1.79M

+15.45%

Mr. Gareth Sheridan

Chief Executive Officer, Founder, Director

1.79M

+15.45%

Mr. Gareth Sheridan

Chief Executive Officer, Founder, Director

1.79M

+15.45%

Mr. Serguei Melnik

Chairman of the Board, President, Company Secretary

839.00K

-11.97%

Mr. Serguei Melnik

Chairman of the Board, President, Company Secretary

839.00K

-11.97%

Mr. Serguei Melnik

Chairman of the Board, President, Company Secretary

839.00K

-11.97%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Nutriband Inc?



Los cinco principales accionistas de Nutriband Inc son: Mr. Gareth Sheridan

¿Cuántas instituciones poseen acciones de Nutriband Inc (NTRB)?



A fecha de 2026Q1, 45 instituciones poseen acciones de Nutriband Inc, con un valor de mercado combinado de aproximadamente 579.57K, lo que representa el 4.77% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 106153.00.